Ester Industries Q1 FY27 Earnings Call — Analysis (NSE: ESTER)
Ester Industries turned profitable in Q1FY27 driven by BOPET price recovery and operating leverage, while targeting 50-60% VAS mix over the next 2-3 years.
Result quality: strong — Loss reversed. Management sentiment: optimistic.
The take
Q1FY27 Consolidated Total Income ₹441.9 Cr ( +27.4% YoY ) . New guidance — FY29 consolidated revenue target ₹2,000 Cr to ₹2,200 Cr . New story: ELITe JV Commercial De-risking .
Results
Consolidated revenue grew 27.4% YoY to ₹441.9 Cr with EBITDA doubling to ₹58.9 Cr (13.3% margin) and PAT turning positive at ₹18.6 Cr.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Consolidated Total Income | ₹441.9 Cr | +27.4% | yoy · Q1FY27 · vs ₹346.9 Cr in Q1FY26 |
| Consolidated EBITDA | ₹58.9 Cr | +103.4% | yoy · Q1FY27 · vs ₹28.96 Cr in Q1FY26 |
| Consolidated EBITDA Margin | 13.3% | +500 bps | yoy · Q1FY27 · vs 8.3% in Q1FY26 |
| Consolidated PAT | ₹18.6 Cr | yoy · Q1FY27 · vs loss of ₹7.2 Cr in Q1FY26 | |
| Standalone Revenue | ₹347.7 Cr | +22.0% | yoy · Q1FY27 · vs ₹284.9 Cr in Q1FY26 |
| Standalone EBITDA | ₹40.0 Cr | +25.2% | yoy · Q1FY27 · vs ₹31.95 Cr in Q1FY26 |
| Standalone PAT | ₹14.5 Cr | +50.5% | yoy · Q1FY27 · vs ₹9.6 Cr in Q1FY26 |
| Ester Filmtech Revenue | ₹159.6 Cr | +62.7% | yoy · Q1FY27 · vs ₹98.1 Cr in Q1FY26 |
| Ester Filmtech EBITDA | ₹19.5 Cr | yoy · Q1FY27 · vs loss of ₹2.7 Cr in Q1FY26 | |
| Ester Filmtech PAT | ₹4.7 Cr | yoy · Q1FY27 · vs loss of ₹16.5 Cr in Q1FY26 | |
| Film Segment Revenue | ₹399.4 Cr | +38.0% | yoy · Q1FY27 · vs ₹289.4 Cr in Q1FY26 |
| Film Segment EBIT | ₹39.1 Cr | +466.7% | yoy · Q1FY27 · vs ₹6.9 Cr in Q1FY26 |
| Specialty Polymers Revenue | ₹32.7 Cr | -32.0% | yoy · Q1FY27 · vs ₹48.1 Cr in Q1FY26 |
| Specialty Polymers EBIT | ₹14.8 Cr | -2.6% | yoy · Q1FY27 · vs ₹15.2 Cr in Q1FY26 |
| rPET Revenue | ₹17.5 Cr | +24.0% | yoy · Q1FY27 · vs ₹14.1 Cr in Q1FY26 |
| Gross Debt | ₹722 Cr | point_in_time · Q1FY27 · as of Jun-26 | |
| Cash and Liquid Investments | ₹236 Cr | point_in_time · Q1FY27 · as of Jun-26 |
Guidance
Management targets reaching ₹2,000-2,200 Cr consolidated revenue in 2-3 years, raising VAS film mix to 50-60%, and paring gross debt by ₹100 Cr in FY27.
What management committed to
- [Ester Industries] is targeting [Value-Added Specialty (VAS) products] proportion at about 50% to 60% over the next 2 to 3 years. — 50% to 60%, FY29
- [Ester Industries] is targeting VAS product contribution up to 35% in the exit quarter [Q4FY27]. — 35%, Q4FY27
- [Ester Industries] targets generating INR 2,000 crores to INR 2,200 crores of revenue with [existing business segments] in next 2 to 3 years. — INR2,000 crores to INR2,200 crores, FY29
- [Ester Industries] is targeting growth at a CAGR of 20% over the next 3 to 5 years in the [Specialty Polymer segment]. — 20%, FY31
- [Ester Industries] targets reducing gross debt by around INR 100 crores in [FY27]. — around INR100 crores, FY27
- [ELITe Joint Venture facility] is targeted to become operational in calendar year 2028. — CY 2028, FY29
- [Ester Industries] will hit more than 100% of the rated capacity on [rPET] by the exit quarter of this financial year [Q4FY27]. — more than 100%, Q4FY27
- [Ester Industries] will not execute any major capex in FY27 apart from sustenance and maintenance capex. — FY27
Key themes
Operational turnaround and specialty mix expansion
How the narrative shifted
- BOPET Supply-Demand Tightening and Price Firmness: Management sees structural stability in global BOPET prices and domestic demand growth outstripping supply additions for the next 6-8 quarters.
- Specialty & VAS Mix Migration: Transforming portfolio towards specialized high-barrier films and polymers to de-link profitability from commodity spread cycles.
- Regulatory Pull from Circular Economy (PWMR): Indian Plastic Waste Management Rules and brand sustainability goals are driving substitution toward food-grade BOPET and rPET.
- ELITe JV Commercial De-risking: Offtake commitments from Nike and another major sports brand validate proprietary textile-to-textile recycling economics prior to 2028 commissioning.
- Balance Sheet Deleveraging: Prioritizing debt reduction by ₹100 Cr in FY27 using internal cash generation while shielding Ester's balance sheet from JV project debt.
Operational commentary
- Value-Added Specialty (VAS) film volume increased 23% YoY to 6,368 MT, contributing 29% to total film volumes versus 24% in Q1FY26.
- Consolidated BOPET film capacity utilization reached 84% (Standalone 85%, Ester Filmtech 83%), supported by strong domestic demand and export recovery.
- ELITe chemical recycling 50:50 JV with Loop Industries secured an LOI from a leading global sports brand for up to 15,000 MT/year of resin, following Nike's earlier anchor commitment.
- ELITe JV completed FEED study via Tata Consulting Engineers; Toyo Engineering appointed for detailed engineering, with land acquisition closing in 2 months.
- US Supreme Court rejected punitive/reciprocal trade tariffs, allowing Ester to regain lost US market share in BOPET films.
- PTA and MEG raw material requirements remain 100% locally contracted on annual terms without availability disruption.
Analyst Q&A
Q. Can the company maintain the Q1 earnings run-rate for the remaining 3 quarters without one-off gains?
Yes, management expects sustainable earnings for the next 6 to 8 quarters due to stable global pricing, favourable supply-demand dynamics, and higher volume placement.
Q. Specific numerical revenue, EBITDA, and PAT guidance for FY27 and FY28.
Management refrained from giving specific point targets on revenue and EBITDA for FY27/FY28, citing general confidence in sustainable growth.
Q. Exact cost arbitrage/margin contribution of captive rPET usage versus external procurement.
Declined to disclose specific cost arbitrage numbers citing competitive sensitivity, though confirming captive rPET captures supplier margin and is cheaper than virgin raw material.
Q. Status of promoter share transfer and succession planning.
Executive Director stated that management is fully professionalized and the share transfer by Mr. Singhania to his son is an internal family matter.
Research and educational content only. Not investment advice.